Logo image of ALREW.PA

REWORLD (ALREW.PA) Stock Fundamental Analysis

EPA:ALREW - Euronext Paris - Matif - FR0010820274 - Common Stock - Currency: EUR

1.68  -0.04 (-2.33%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALREW. ALREW was compared to 59 industry peers in the Media industry. ALREW has an average financial health and profitability rating. ALREW is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALREW was profitable.
ALREW had a positive operating cash flow in the past year.
ALREW had positive earnings in each of the past 5 years.
ALREW had a positive operating cash flow in each of the past 5 years.
ALREW.PA Yearly Net Income VS EBIT VS OCF VS FCFALREW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 3.65%, ALREW is doing good in the industry, outperforming 64.41% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.95%, ALREW is in line with its industry, outperforming 59.32% of the companies in the same industry.
ALREW has a better Return On Invested Capital (8.44%) than 67.80% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALREW is in line with the industry average of 8.79%.
Industry RankSector Rank
ROA 3.65%
ROE 10.95%
ROIC 8.44%
ROA(3y)4.63%
ROA(5y)4.84%
ROE(3y)15.78%
ROE(5y)17.69%
ROIC(3y)10.02%
ROIC(5y)11.09%
ALREW.PA Yearly ROA, ROE, ROICALREW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

ALREW has a Profit Margin (4.36%) which is comparable to the rest of the industry.
ALREW's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 8.81%, ALREW perfoms like the industry average, outperforming 57.63% of the companies in the same industry.
ALREW's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 61.10%, ALREW is in the better half of the industry, outperforming 61.02% of the companies in the same industry.
ALREW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.81%
PM (TTM) 4.36%
GM 61.1%
OM growth 3Y-11.07%
OM growth 5Y-15.59%
PM growth 3Y-19.13%
PM growth 5Y-12.76%
GM growth 3Y-3.09%
GM growth 5Y19.36%
ALREW.PA Yearly Profit, Operating, Gross MarginsALREW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALREW is still creating some value.
Compared to 1 year ago, ALREW has about the same amount of shares outstanding.
Compared to 5 years ago, ALREW has more shares outstanding
ALREW has a better debt/assets ratio than last year.
ALREW.PA Yearly Shares OutstandingALREW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ALREW.PA Yearly Total Debt VS Total AssetsALREW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALREW has an Altman-Z score of 1.72. This is a bad value and indicates that ALREW is not financially healthy and even has some risk of bankruptcy.
ALREW's Altman-Z score of 1.72 is in line compared to the rest of the industry. ALREW outperforms 57.63% of its industry peers.
The Debt to FCF ratio of ALREW is 10.26, which is on the high side as it means it would take ALREW, 10.26 years of fcf income to pay off all of its debts.
ALREW has a worse Debt to FCF ratio (10.26) than 64.41% of its industry peers.
A Debt/Equity ratio of 0.87 indicates that ALREW is somewhat dependend on debt financing.
The Debt to Equity ratio of ALREW (0.87) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.26
Altman-Z 1.72
ROIC/WACC1.45
WACC5.81%
ALREW.PA Yearly LT Debt VS Equity VS FCFALREW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALREW has a Current Ratio of 1.52. This is a normal value and indicates that ALREW is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.52, ALREW is doing good in the industry, outperforming 79.66% of the companies in the same industry.
A Quick Ratio of 1.50 indicates that ALREW should not have too much problems paying its short term obligations.
ALREW has a better Quick ratio (1.50) than 83.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.5
ALREW.PA Yearly Current Assets VS Current LiabilitesALREW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for ALREW have decreased by -8.61% in the last year.
ALREW shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.09% yearly.
ALREW shows a decrease in Revenue. In the last year, the revenue decreased by -2.65%.
Measured over the past years, ALREW shows a quite strong growth in Revenue. The Revenue has been growing by 12.68% on average per year.
EPS 1Y (TTM)-8.61%
EPS 3Y-18.34%
EPS 5Y-6.09%
EPS Q2Q%17.2%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y4.41%
Revenue growth 5Y12.68%
Sales Q2Q%-4.34%

3.2 Future

ALREW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.74% yearly.
The Revenue is expected to grow by 2.67% on average over the next years.
EPS Next Y15.91%
EPS Next 2Y14.15%
EPS Next 3Y16.74%
EPS Next 5YN/A
Revenue Next Year0.77%
Revenue Next 2Y1.47%
Revenue Next 3Y2.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALREW.PA Yearly Revenue VS EstimatesALREW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALREW.PA Yearly EPS VS EstimatesALREW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.67, the valuation of ALREW can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of ALREW indicates a rather cheap valuation: ALREW is cheaper than 94.92% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.85, ALREW is valued rather cheaply.
The Price/Forward Earnings ratio is 3.20, which indicates a rather cheap valuation of ALREW.
ALREW's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALREW is cheaper than 98.31% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.77, ALREW is valued rather cheaply.
Industry RankSector Rank
PE 4.67
Fwd PE 3.2
ALREW.PA Price Earnings VS Forward Price EarningsALREW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALREW indicates a rather cheap valuation: ALREW is cheaper than 81.36% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALREW is valued a bit cheaper than 76.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.39
EV/EBITDA 3.58
ALREW.PA Per share dataALREW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALREW's earnings are expected to grow with 16.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y14.15%
EPS Next 3Y16.74%

0

5. Dividend

5.1 Amount

No dividends for ALREW!.
Industry RankSector Rank
Dividend Yield N/A

REWORLD

EPA:ALREW (4/30/2025, 7:00:00 PM)

1.68

-0.04 (-2.33%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-23 2025-09-23
Inst Owners14.96%
Inst Owner ChangeN/A
Ins Owners23.34%
Ins Owner ChangeN/A
Market Cap97.51M
Analysts89.09
Price Target4.62 (175%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.05%
PT rev (3m)-11.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.73%
EPS NY rev (3m)-24.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.51%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 4.67
Fwd PE 3.2
P/S 0.18
P/FCF 5.39
P/OCF 3.66
P/B 0.46
P/tB N/A
EV/EBITDA 3.58
EPS(TTM)0.36
EY21.43%
EPS(NY)0.53
Fwd EY31.27%
FCF(TTM)0.31
FCFY18.57%
OCF(TTM)0.46
OCFY27.34%
SpS9.21
BVpS3.67
TBVpS-2.37
PEG (NY)0.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.65%
ROE 10.95%
ROCE 10.14%
ROIC 8.44%
ROICexc 10.38%
ROICexgc 143.53%
OM 8.81%
PM (TTM) 4.36%
GM 61.1%
FCFM 3.39%
ROA(3y)4.63%
ROA(5y)4.84%
ROE(3y)15.78%
ROE(5y)17.69%
ROIC(3y)10.02%
ROIC(5y)11.09%
ROICexc(3y)12.89%
ROICexc(5y)19.45%
ROICexgc(3y)259.8%
ROICexgc(5y)N/A
ROCE(3y)12.04%
ROCE(5y)13.33%
ROICexcg growth 3Y-90.01%
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.99%
ROICexc growth 5Y-22.15%
OM growth 3Y-11.07%
OM growth 5Y-15.59%
PM growth 3Y-19.13%
PM growth 5Y-12.76%
GM growth 3Y-3.09%
GM growth 5Y19.36%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.26
Debt/EBITDA 3.39
Cap/Depr 111.17%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 48.64%
Profit Quality 77.74%
Current Ratio 1.52
Quick Ratio 1.5
Altman-Z 1.72
F-Score7
WACC5.81%
ROIC/WACC1.45
Cap/Depr(3y)78.11%
Cap/Depr(5y)67.07%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.51%
Profit Quality(3y)60.69%
Profit Quality(5y)85.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.61%
EPS 3Y-18.34%
EPS 5Y-6.09%
EPS Q2Q%17.2%
EPS Next Y15.91%
EPS Next 2Y14.15%
EPS Next 3Y16.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y4.41%
Revenue growth 5Y12.68%
Sales Q2Q%-4.34%
Revenue Next Year0.77%
Revenue Next 2Y1.47%
Revenue Next 3Y2.67%
Revenue Next 5YN/A
EBIT growth 1Y-16.61%
EBIT growth 3Y-7.15%
EBIT growth 5Y-4.89%
EBIT Next Year18.6%
EBIT Next 3Y11.18%
EBIT Next 5YN/A
FCF growth 1Y59.16%
FCF growth 3Y-14.06%
FCF growth 5YN/A
OCF growth 1Y23.54%
OCF growth 3Y-8.92%
OCF growth 5YN/A